• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[血液流变学、微循环与氧合作用。生理病理学与治疗学方面]

[Hemorrheology, microcirculation and oxygenation. Physiopathological and therapeutic aspects].

作者信息

Ehrly M

机构信息

Service de Médecine Interne, Hôpital Universitaire Johann-Wolfgang-Goethe, Frankfurt-am-Main.

出版信息

Rev Fr Gynecol Obstet. 1991 Feb 25;86(2 Pt 2):131-8.

PMID:1767162
Abstract

The oxygen transport chain in mammalians depends on adequate oxygen uptake, oxygen transport and oxygen delivery. In diseases with underlying perfusion disorders, for example chronic occlusive arterial disease, the oxygen uptake by the lungs is not altered and thus the oxygen saturation of arterial blood is normal. In this case however the reduced blood flow does impair the oxygen transport to tissue. Blood flow depends on several factors. In diseases with low flow states, the flow properties of blood play a major role because the viscosity of blood increases in the sense of a vicious circle at low flow rates. Since the hematocrit is one of the determining factors of blood viscosity, one possibility to improve microcirculatory blood flow is to decrease the hematocrit value. The problem is however to reach a hematocrit range whereby the viscosity of blood is markedly improved but without reduction in the oxygen transport capacity. Other methods to increase microcirculatory blood flow at constant hematocrit values are the improvement of red cell deformability and the reduction of erythrocyte aggregation. All these methods are nowadays used in a number of diseases, in which a "hyperviscosity syndrome" is present. In general, an improvement of hemorheological factors like blood and plasma viscosity, erythrocyte deformability and erythrocyte aggregation will improve microcirculatory flow and enhance oxygen supply to tissue.

摘要

哺乳动物的氧运输链依赖于充足的氧摄取、氧运输和氧输送。在伴有潜在灌注障碍的疾病中,例如慢性闭塞性动脉疾病,肺的氧摄取未改变,因此动脉血的氧饱和度正常。然而在这种情况下,血流减少确实会损害向组织的氧运输。血流取决于几个因素。在低血流状态的疾病中,血液的流动特性起主要作用,因为在低流速时血液粘度会呈恶性循环增加。由于血细胞比容是血液粘度的决定因素之一,改善微循环血流的一种可能性是降低血细胞比容值。然而问题在于要达到一个血细胞比容范围,在此范围内血液粘度明显改善,但又不降低氧运输能力。在血细胞比容值恒定的情况下增加微循环血流的其他方法是改善红细胞变形性和减少红细胞聚集。如今所有这些方法都用于许多存在“高粘滞综合征”的疾病中。一般来说,改善血液和血浆粘度、红细胞变形性和红细胞聚集等血液流变学因素将改善微循环血流并增强向组织的氧供应。

相似文献

1
[Hemorrheology, microcirculation and oxygenation. Physiopathological and therapeutic aspects].[血液流变学、微循环与氧合作用。生理病理学与治疗学方面]
Rev Fr Gynecol Obstet. 1991 Feb 25;86(2 Pt 2):131-8.
2
Erythrocyte aggregation in clinical medicine.临床医学中的红细胞聚集
Klin Wochenschr. 1986 Oct 15;64(20):1081-4.
3
New trends in clinical hemorheology: an introduction to the concept of the hemorheological profile.临床血液流变学的新趋势:血液流变学特征概念介绍
Schweiz Med Wochenschr Suppl. 1991;43:41-9.
4
[Hemorrheology in clinical practice. Applications in an in vitro study of troxerutin].[临床实践中的血液流变学。曲克芦丁体外研究中的应用]
Rev Fr Gynecol Obstet. 1991 Feb 25;86(2 Pt 2):200-5.
5
[Blood fluidity in essential hypertension, arterial occlusive disease and diabetic angiopathies].[原发性高血压、动脉闭塞性疾病及糖尿病性血管病变中的血液流动性]
Z Gesamte Inn Med. 1991 Nov;46(16):610-4.
6
Rheology in the microcirculation in normal and low flow states.正常和低流量状态下微循环中的流变学
Adv Shock Res. 1982;8:71-80.
7
[Rheologic particulars of venous flow. Physiopathologic consequences].[静脉血流的流变学特性。生理病理后果]
J Mal Vasc. 1989;14(2):107-10.
8
Blood rheology and physiology of microcirculation.血液流变学与微循环生理学
Ric Clin Lab. 1981;11 Suppl 1:13-33.
9
[Changes in blood rheology and microcirculation after preparatory combined thrombocytapheresis and plasmapheresis].[血小板单采和血浆置换联合预处理后血液流变学和微循环的变化]
Beitr Infusionsther Transfusionsmed. 1997;34:123-7.
10
Hemorheological mechanisms in Alzheimer's disease.阿尔茨海默病中的血液流变学机制。
Microcirculation. 2007 Aug;14(6):627-34. doi: 10.1080/10739680701411056.